Drugs / L-thyroxin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01840332 | Apr 2013 → Feb 2014 | thyroid cancer | University of Tartu | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01458600 Background | Sep 2006 → Feb 2016 | Graves disease | Mikael Lantz | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-thyroxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01840332 ↗ |